109 related articles for article (PubMed ID: 24103748)
1. Ephrin-A1 expression induced by S100A8 is mediated by the toll-like receptor 4.
Ieguchi K; Omori T; Komatsu A; Tomita T; Deguchi A; Maru Y
Biochem Biophys Res Commun; 2013 Nov; 440(4):623-9. PubMed ID: 24103748
[TBL] [Abstract][Full Text] [Related]
2. ADAM12-cleaved ephrin-A1 contributes to lung metastasis.
Ieguchi K; Tomita T; Omori T; Komatsu A; Deguchi A; Masuda J; Duffy SL; Coulthard MG; Boyd A; Maru Y
Oncogene; 2014 Apr; 33(17):2179-90. PubMed ID: 23686306
[TBL] [Abstract][Full Text] [Related]
3. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J
Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451
[TBL] [Abstract][Full Text] [Related]
4. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase.
Hiratsuka S; Watanabe A; Sakurai Y; Akashi-Takamura S; Ishibashi S; Miyake K; Shibuya M; Akira S; Aburatani H; Maru Y
Nat Cell Biol; 2008 Nov; 10(11):1349-55. PubMed ID: 18820689
[TBL] [Abstract][Full Text] [Related]
5. Imbalance of Clara cell-mediated homeostatic inflammation is involved in lung metastasis.
Tomita T; Sakurai Y; Ishibashi S; Maru Y
Oncogene; 2011 Aug; 30(31):3429-39. PubMed ID: 21399660
[TBL] [Abstract][Full Text] [Related]
6. Roles of EphA1/A2 and ephrin-A1 in cancer.
Ieguchi K; Maru Y
Cancer Sci; 2019 Mar; 110(3):841-848. PubMed ID: 30657619
[TBL] [Abstract][Full Text] [Related]
7. Analysis of ADAM12-Mediated Ephrin-A1 Cleavage and Its Biological Functions.
Ieguchi K; Tomita T; Takao T; Omori T; Mishima T; Shimizu I; Tognolini M; Lodola A; Tsunoda T; Kobayashi S; Wada S; Maru Y
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33804570
[TBL] [Abstract][Full Text] [Related]
8. Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.
Deguchi A; Tomita T; Ohto U; Takemura K; Kitao A; Akashi-Takamura S; Miyake K; Maru Y
Oncogene; 2016 Mar; 35(11):1445-56. PubMed ID: 26165843
[TBL] [Abstract][Full Text] [Related]
9. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
[TBL] [Abstract][Full Text] [Related]
10. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis.
Hiratsuka S; Watanabe A; Aburatani H; Maru Y
Nat Cell Biol; 2006 Dec; 8(12):1369-75. PubMed ID: 17128264
[TBL] [Abstract][Full Text] [Related]
11. Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression.
Straume O; Akslen LA
Am J Pathol; 2002 Mar; 160(3):1009-19. PubMed ID: 11891198
[TBL] [Abstract][Full Text] [Related]
12. The Measure of DAMPs and a role for S100A8 in recruiting suppressor cells in breast cancer lung metastasis.
Vrakas CN; O'Sullivan RM; Evans SE; Ingram DA; Jones CB; Phuong T; Kurt RA
Immunol Invest; 2015; 44(2):174-88. PubMed ID: 25255046
[TBL] [Abstract][Full Text] [Related]
13. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.
Brantley-Sieders DM; Caughron J; Hicks D; Pozzi A; Ruiz JC; Chen J
J Cell Sci; 2004 Apr; 117(Pt 10):2037-49. PubMed ID: 15054110
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma].
Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival.
Herath NI; Spanevello MD; Sabesan S; Newton T; Cummings M; Duffy S; Lincoln D; Boyle G; Parsons PG; Boyd AW
BMC Cancer; 2006 Jun; 6():144. PubMed ID: 16737551
[TBL] [Abstract][Full Text] [Related]
16. The proangiogenic factor ephrin-A1 is up-regulated in radioresistant murine tumor by irradiation.
Nojiri K; Iwakawa M; Ichikawa Y; Imadome K; Sakai M; Nakawatari M; Ishikawa K; Ishikawa A; Togo S; Tsujii H; Shimada H; Imai T
Exp Biol Med (Maywood); 2009 Jan; 234(1):112-22. PubMed ID: 18997097
[TBL] [Abstract][Full Text] [Related]
17. Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK.
Liu DP; Wang Y; Koeffler HP; Xie D
Int J Oncol; 2007 Apr; 30(4):865-71. PubMed ID: 17332925
[TBL] [Abstract][Full Text] [Related]
18. Experimental hypoxia does not influence gene expression and protein synthesis of Eph receptors and ephrin ligands in human melanoma cells in vitro.
Reissenweber B; Mosch B; Pietzsch J
Melanoma Res; 2013 Apr; 23(2):85-95. PubMed ID: 23358429
[TBL] [Abstract][Full Text] [Related]
19. Eph-A2 promotes permeability and inflammatory responses to bleomycin-induced lung injury.
Carpenter TC; Schroeder W; Stenmark KR; Schmidt EP
Am J Respir Cell Mol Biol; 2012 Jan; 46(1):40-7. PubMed ID: 21799118
[TBL] [Abstract][Full Text] [Related]
20. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
